First, we observed an overall trend of lower prescribing prevalence of anticoagulants and antiplatelets in patients with liver disease compared with those without liver disease.
← all excerpts
Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding.
1
—
—